Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Urinary Bladder Neoplasms × Celecoxib × Clear all

Phase

Phase NA 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Sarcoma 3 Neoplasms 3 Neoplasm Metastasis 3 Thymoma 2 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Melanoma 2 Leukemia, Myelomonocytic, Chronic 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Neuroblastoma 1

Interventions

pembrolizumab 22 Gemcitabine 17 Nivolumab 10 Cisplatin 9 Docetaxel 8 atezolizumab 6 Paclitaxel 6 durvalumab 5 Radiotherapy 5 Carboplatin 5 fludarabine 3 enfortumab vedotin 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Fluorouracil 3 Cyclophosphamide 3 tremelimumab 2 poly ICLC 2 infigratinib 2 erdafitinib 2 cc-486 2 belinostat 2 amminedichloro(2-methylpyridine)platinum(II) 2 aflibercept 2 Vorinostat 2 Trastuzumab 2 Suramin 2 Specimen Handling 2 Sorafenib 2 Rogaratinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02885974 2025-07-28

BLAST

Baylor College of Medicine

Phase 1 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡